Glottic carcinoma is curable by either surgery or radiotherapy. A total of 60 patients were treated by radiation alone at the Northern Israel Oncology Center, Rambam Medical Center, Haifa, between 1970 and 1980. Twentynine (48%) were classified as TI No and 31 (52%) as T2 No. All patients received r
Second malignant neoplasia in early (TIS-T1) glottic carcinoma
✍ Scribed by Elisabeth V. Sjögren; Simone Snijder; Joost van Beekum; Robert Jan Baatenburg de Jong
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 172 KB
- Volume
- 28
- Category
- Article
- ISSN
- 1043-3074
No coin nor oath required. For personal study only.
✦ Synopsis
Background:
We performed a population-based study to determine the incidence and patterns of second malignant neoplasia (smn) in early glottic carcinoma.
Methods:
All patients diagnosed with tis-t1 glottic carcinoma in the southwest of the netherlands between 1982 and 1993 (359) were included. sources of the data were patient charts and the regional cancer registry.
Results:
Smn incidence was 27.7% (median follow-up, 89 months). observed-to-expected ratios were increased for lung, bladder, urinary tract, pancreatic, colorectal, and head and neck cancers. the incidence of head and neck and esophageal cancer was surprisingly low.
Conclusions:
Patients with early glottic carcinoma are at a reliably increased risk of the development of tumors not only in the areas of the upper aerodigestive tract, but also in the bladder, pancreas, and colorectum. the low incidence of head and neck and esophageal tumors does not appear to support routine panendoscopy in this patient population.
📜 SIMILAR VOLUMES
The modern use of microlaryngology is improving the diagnosis and treatment of early and advanced glottic laryngeal lesions. Microlaryngology is a microscopic laryngoscopic technique that is used to carry out laryngeal tumor evaluation and biopsy. For early, small, and advanced laryngeal glottic les
## Abstract ## Background. Laser cordectomy is gaining popularity for treatment of early glottic carcinoma, but little is known about vocal and quality of life (QOL) outcomes as a function of extent of resection. We prospectively examined QOL and vocal function of patients with carcinoma in situ (